Does NADOLOL Cause Haematochezia? 181 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 181 reports of Haematochezia have been filed in association with NADOLOL (Nadolol). This represents 9.6% of all adverse event reports for NADOLOL.
181
Reports of Haematochezia with NADOLOL
9.6%
of all NADOLOL reports
0
Deaths
180
Hospitalizations
How Dangerous Is Haematochezia From NADOLOL?
Of the 181 reports, 180 (99.4%) required hospitalization, and 1 (0.6%) were considered life-threatening.
Is Haematochezia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NADOLOL. However, 181 reports have been filed with the FAERS database.
What Other Side Effects Does NADOLOL Cause?
Drug ineffective (989)
Macular degeneration (781)
Off label use (330)
Weight decreased (324)
Nausea (295)
Dyspepsia (263)
Abdominal pain (259)
Therapeutic product effect incomplete (251)
Pain (244)
Malaise (241)
What Other Drugs Cause Haematochezia?
VEDOLIZUMAB (5,215)
ADALIMUMAB (4,008)
INFLIXIMAB (3,539)
ASPIRIN (2,379)
RIVAROXABAN (1,623)
MESALAMINE (1,456)
CLOPIDOGREL BISULFATE (1,390)
APIXABAN (1,312)
METHOTREXATE (1,133)
TOFACITINIB (1,118)
Which NADOLOL Alternatives Have Lower Haematochezia Risk?
NADOLOL vs NADROPARIN
NADOLOL vs NAFARELIN
NADOLOL vs NAFCILLIN
NADOLOL vs NAFCILLIN\NAFCILLIN
NADOLOL vs NAFRONYL